{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "378", "lead_paragraph": "Handing the reins temporarily to three executives, with three directors to \u201coversee and support\u201d them, shows how reliant on one man the drug company now is.", "pub_date": "2015-12-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant\u2019s Latest Fix Underscores Its Challenges", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "Handing the reins temporarily to three executives, with three directors to \u201coversee and support\u201d them, shows how reliant on one man the drug company now is.", "multimedia": [{"height": 126, "url": "images/2015/12/26/business/26VALEANT/26VALEANT-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/26/business/26VALEANT/26VALEANT-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 554, "url": "images/2015/12/26/business/26VALEANT/26VALEANT-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "554", "xlarge": "images/2015/12/26/business/26VALEANT/26VALEANT-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/26/business/26VALEANT/26VALEANT-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/26/business/26VALEANT/26VALEANT-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/29/business/dealbook/valeants-latest-fix-underscores-its-challenges.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Appointments and Executive Changes", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "56818c2f38f0d80161f69254", "source": "The New York Times"}